Document is current
Any future updates will be listed below
-
Authors
Cruces Olivar, Marcos
Burboa, Allan D.
Gómez, Yolanda M.
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile
Journal Title: Reumatología Clínica
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2025.501946
Content Type: simple-article
Copyright: © 2025 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) y Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
